Viewpoints

Artificial Intelligence promises a range of practical applications to improve efficiencies within the medical sector; in particular, the...

On 21 May 2024, the UK Medicines and Healthcare products Regulation Agency (MHRA) issued a statement of policy intent describing a...

Yesterday, the government announced that the UK has secured commitment from the world’s leading investors of nearly £30bn. The...

The UK government has had significant issues with the implementation the UK’s post-Brexit products safety conformity mark, the UKCA mark,...

During Covid-19, UK clinical research was very much at the front and centre of the global effort to find a vaccine. As we started to...

On 25 May 2022, the Supreme Court (UKSC) overturned the Court of Appeal’s costs ruling in the Pfizer/Flynn case regarding excessive...

The CMA’s full text decision in the long-running Hydrocortisone case, originally initiated in 2016 and in which the CMA imposed record...